Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I
296C811C820
Molecules 27(3):950 Lin CC, Huang HH, Hu CW, Chen BH, Chong IW, Chao YY et al (2014) Trace elements, oxidative stress and glycemic control in young people with type 1 diabetes mellitus
Obeticholic acid (OCA), the most extensively studied FXR agonist, was evaluated in the FLINT trial (NCT01265498), where non-cirrhotic NASH patients receiving 25 mg daily for 72 weeks experienced notable improvements in liver histology, including reductions in steatosis, inflammation, and fibrosis [65,66,67,68]